Q2 2026 Nuwellis Inc Earnings Call Transcript
Key Points
- Nuwellis Inc (NUWE) reported a 14% increase in Q2 2026 revenue to $1.97 million, with U.S. revenue up 17%.
- The company sold 24 consoles in the first half of 2026, compared to only 5 in the same period of 2025, expanding its installed base.
- Gross margin improved significantly to 76% in Q2 2026, up from 56% in the prior-year quarter, driven by higher pricing and contract manufacturing benefits.
- Nuwellis Inc (NUWE) is advancing its pediatric label expansion to include patients weighing 5 kg and above, with a planned FDA submission in Q4 2026.
- The company raised approximately $12.7 million in gross proceeds through financing activities, strengthening its cash position and simplifying its capital structure.
- Nuwellis Inc (NUWE) received a notice of allowance for its dual-lumen midline catheter technology, which could support less invasive peripheral access for extracorporeal therapies.
- Nuwellis Inc (NUWE) reported a net loss of approximately $4.8 million in Q2 2026, though improved from a $12.6 million loss in the prior-year quarter.
- Operating expenses increased to $4.7 million in Q2 2026, up from $3.9 million in the prior-year quarter, reflecting higher investment costs.
- The company's cash position remains low at $3.9 million as of June 30, 2026, despite subsequent financing efforts.
- Lower OUS service and rental revenue moderated overall revenue growth, indicating weakness in international markets.
- Nuwellis Inc (NUWE) continues to rely on external financing to support operations, as evidenced by multiple capital raises in 2026.
- The company faces regulatory and development risks with its proposed pediatric label expansion and Clarity Prime product, which is not expected to launch until 2027.
Good morning and welcome to New Ellis Earnings Conference Call for the second quarter ended June 30, 2026. (Operator Instructions) I would now like to turn the conference over to Leah McMullen, Director of Communications. Please go ahead.
Thank you, Operator. Thank you for joining today's conference call to discuss New Ellis' corporate developments and financial results for the second quarter, ended June 30, 2026. Joining me today are Mike McCormick, New Ellis' newly appointed President and Chief Executive Officer, and Carissa Schultz, Chief Financial Officer. Earlier today, Newellis released its financial results for the second quarter of 2026. If you have not received the earnings release, please visit the investor page on the company's website. During this conference call, the company will be making forward-looking statements. All forward-looking statements made during today's call will be protected under the Private Securities Litigation Reform Act of 1995. Any statements that relate to our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
